(4502) – Corporate News
-
Takeda (TAK) Announces U.S. FDA Approval of sNDA for ICLUSIG in Adult Patients with Newly Diagnosed Ph+ ALL
-
Takeda’s (TAK) GAMMAGARD LIQUID Approved by U.S. FDA for Adults with CIDP
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to 4502 Stock Lookup